Literature DB >> 15074733

Should all breast cancer patients with symptomatic bone metastasis be treated with bisphosphonates? The case against.

P J Hoskin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15074733     DOI: 10.1016/j.clon.2004.01.003

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  2 in total

Review 1.  Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer.

Authors:  Paul L McCormack; Greg L Plosker
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Zoledronic acid: a review of its use in patients with advanced cancer.

Authors:  Caroline M Perry; David P Figgitt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.